- Home
- CALY vs CLDX Comparison
CALY vs CLDX Comparison
Compare CALY & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CALY | CLDX |
|---|---|---|
| Founded | 1982 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.0B |
| IPO Year | 1994 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CALY | CLDX |
|---|---|---|
| Price | $14.28 | $31.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 15 |
| Target Price | $20.40 | ★ $63.07 |
| AVG Volume (30 Days) | 1.7M | ★ 1.8M |
| Earning Date | 11-05-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.08 | N/A |
| EPS | ★ 0.87 | N/A |
| Revenue | ★ $2,060,100,000.00 | $12,743,000.00 |
| Revenue This Year | $0.20 | $19.74 |
| Revenue Next Year | $3.30 | $438.11 |
| P/E Ratio | $16.40 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $12.26 | $22.10 |
| 52 Week High | $20.28 | $45.14 |
Technical Indicators
Market Signals| Indicator | CALY | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 32.97 | 30.11 |
| Support Level | $14.10 | $28.82 |
| Resistance Level | $14.73 | $31.80 |
| Average True Range (ATR) | 0.37 | 2.09 |
| MACD | 0.03 | -0.29 |
| Stochastic Oscillator | 22.06 | 5.78 |
Price Performance
Historical ComparisonAbout CALY Callaway Golf Company
Callaway Golf Co is a golf equipment, gear and apparel company with a portfolio of world-wide brands, including Callaway Golf, Odyssey, TravisMathew, and OGIO. Callaway designs, manufactures, and sells high-performance golf clubs, golf balls, apparel, bags, and other accessories-setting the standard for performance in the game of golf. The company has two operating and reportable business segments: Golf Equipment and Apparel, Gear and Other. Geographically, the company operates in United States, Europe, Asia, and Rest of World, of which it derives maximum revenue from United States.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.